TRAFALGAR INTERNATIONAL, INC.
Public company- Headquarters
- MIAMI, Florida
- Ticker
- TRFA
- CIK
- 0001695473
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOPorfirio Sanchez Talavera | Sep 21, 2026 | Departed |
| COOCarlos Septién | Sep 21, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Polomar Health Services, Inc.
director departs: Alexandra Peterson
- Alaunos Therapeutics, Inc.
director appointed: Peter Harwin
- Inhibitor Therapeutics, Inc.
Director appointed: Francis E. O’Donnell
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive departure
CEO departs: Porfirio Sanchez Talavera
Porfirio Sanchez Talavera, Chief Executive Officer of TRAFALGAR INTERNATIONAL, INC., resigns the role, effective September 18, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 21, 2026Role: Chief Executive Officer
- Executive appointment
CEO appointed: Carlos Septién
Carlos Septién was named Chief Executive Officer of TRAFALGAR INTERNATIONAL, INC., effective September 18, 2026. Carlos Septién succeeds Porfirio Sanchez Talavera. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 21, 2026Role: Chief Executive Officer
- Executive departure
COO departs: Carlos Septién
Carlos Septién, Chief Operating Officer of TRAFALGAR INTERNATIONAL, INC., resigns the role. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 21, 2026Role: Chief Operating Officer
Last verified Nov 8, 2026